Founded in 2009, Ophthalmos® GmbH is a Swiss company in the field of ophthalmology, dedicated to invent, develop, manufacture and market innovative ophthalmic implants and instruments.


The founder and president Hans R. Grieshaber previously led the Grieshaber Company for more than 30 years, a leading ophthalmic instrument enterprise operating in more than 60 countries worldwide. Hans R. Grieshaber holds many achievement awards and serves as board member of several societies in ophthalmology.




Our mission is to improve and preserve the eyesight and quality of life of patients suffering from glaucoma by developing nano-technological implants and fine instruments for advanced and modern glaucoma surgery.


Clinical Research

Ophthalmos® has more than 20 years of experience in research and development of surgical solutions for glaucoma with the goal of providing safe interventions for lowering eye pressure. Hans R. Grieshaber and Robert Stegmann, MD developed viscocanalostomy, the pioneer technique in non-penetrating glaucoma surgery restoring the natural outflow system of the eye. The suture stent in canaloplasty was another innovative idea of Robert Stegmann in canaloplasty before the Canal Expander was invented to replace the suture stent and to make canaloplasty a more controlled and simplified procedure.



Ophthalmos® is located in Schaffhausen, Switzerland.



EN ISO 9001

EN ISO 13485

CE 93/42/EEC, Annex II